CTC technology hammer sound: experts will develop industry standards


In recent years, a non-invasive detection method called liquid biopsy is changing the diagnosis and treatment of cancer. Compared with traditional tissue biopsy, liquid biopsy has the characteristics of dynamic, real-time, easy to obtain samples, light pain and low risk. This technology was once named "Top Ten Breakthrough Technologies of 2015" by MIT Technology Review ".

In recent years, the commercial value of liquid biopsy showed explosive growth. Illumina CEO Jay Flatley has said the liquid biopsy market is worth at least $40 billion. He believes that this technology may be an exciting breakthrough in the field of cancer diagnosis.